1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 25 MAY 2015

Cancer Drug News 25 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Speedy Approvals Increasing Fast Track Designation Appeal
Industry Brief - GlycoMimetics Initiates Phase I/IIl Trial of GMI-1271 In AML
Industry Brief - Opdivo Gains CHMP Positive Opinion For Previously-Treated Advanced Squamous NSCLC
Industry Brief - CVac Phase II Study Shows OS Benefit Over SoC In Second Remission OC
Industry Brief - PsiOxus Raises Funds For Oncolytic Virus/Checkpoint Inhibitor Combination Study
Industry Brief - DSMB Recommends Increasing Patient Sample Size In Xilonix Phase III CRC Study
Industry Trend Analysis - OctreoPharm Acquisition Will Strengthen Ipsen's NET Presence
Industry Brief - Novartis' Afinitor Phase III Study Extends PFS In Advanced GI Or Lung NET
Industry Brief - DNAtrix To Use Alcyone's AMC Delivery Platform For DNX-2401 In Glioblastoma
Industry Brief - Eisai Launches Lenvima In Japan For Unresectable TC
Industry Brief - BioNTech/Genmab Collaborate To Develop Bispecific Abs In Immuno-Oncology
Industry Trend Analysis - Biologics Will Front AstraZeneca's Oncology Reinvigoration
Industry Brief - Sorrento Establishes Subsidiary With Cellular Immunotherapy Focus
Industry Trend Analysis - Local Oncology Presence Continues To Grow
Industry Brief - Cancer Conferences - August 2015

Table Of Contents

Cancer Drug News 25 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.